Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".
Author:Vallejo-Vaz, Antonio J. MD, PhD; Packard, Chris J. DSc; Ray, Kausik K. MD, MPhil
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου